Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B

Background: There is no consensus for the best treatment of complex cutaneous leishmaniasis (CL). We aimed to describe a cohort of CL, focusing on liposomal amphotericin B (L-AmB) treatment outcome. Methods: We performed a retrospective study in Vall d’Hebron University Hospital (Barcelona, Spain)....

Full description

Bibliographic Details

Published in:	Pathogens
Main Authors:	Maria Ubals, Pau Bosch-Nicolau, Adrián Sánchez-Montalvá, Fernando Salvador, Gloria Aparicio-Español, Elena Sulleiro, Aroa Silgado, Antoni Soriano-Arandes, Maria Espiau, Berta Ferrer, Diana Pou, Begoña Treviño, Israel Molina, Vicente García-Patos
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Subjects:	complex cutaneous leishmaniasis cutaneous leishmaniasis liposomal amphotericin B leishmania systemic therapy
Online Access:	https://www.mdpi.com/2076-0817/10/10/1253